Clinical trials
Phase 1 Parkinson Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
385 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 8 |
| 2006 | 8 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 20 |
| 2010 | 10 |
| 2011 | 14 |
| 2012 | 12 |
| 2013 | 15 |
| 2014 | 25 |
| 2015 | 16 |
| 2016 | 13 |
| 2017 | 17 |
| 2018 | 22 |
| 2019 | 28 |
| 2020 | 22 |
| 2021 | 17 |
| 2022 | 21 |
| 2023 | 19 |
| 2024 | 21 |
| 2025 | 23 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 251 |
| Recruiting | 44 |
| Unknown status | 30 |
| Terminated | 21 |
| Not yet recruiting | 15 |
| Withdrawn | 14 |
| Active, not recruiting | 8 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bial - Portela C S.A. | 44 |
| Luye Pharma Group Ltd. | 11 |
| Institute for Neurodegenerative Disorders | 10 |
| H. Lundbeck A/S | 9 |
| MODAG GmbH | 6 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 6 |
| NeuroDerm Ltd. | 6 |
| University of Minnesota | 6 |
| AbbVie | 5 |
| Affiris AG | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 385 |
| Alzheimer Disease | 17 |
| Multiple System Atrophy | 17 |
| Movement Disorders | 12 |
| Parkinsonian Disorders | 11 |
| Neurodegenerative Diseases | 10 |
| Dyskinesias | 7 |
| Tauopathies | 7 |
| Cognitive Dysfunction | 6 |
| Lewy Body Disease | 6 |
Trials
Showing 1 to 25 of 385. Each trial links to its page on Pharma Observatory.
285 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.